跳至主要内容
临床试验/NCT06890390
NCT06890390招募中不适用

TSPO PET in the Evaluation of Neuroinflammation in Patients with Multiple System Atrophy

Min Zhao,MD1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2024年9月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
90
试验地点
1
主要终点
Standard uptake value ratio(SUVR)

研究概览

简要总结

The aim of this study was to apply PET/MR techniques targeting TSPO to explore the temporal and spatial alterations characterizing neuroinflammation in MSA patients, and to assess its value as a biomarker for diagnostic typing, disease severity, and prognosis of MSA disease.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
35 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Age> 35 years old, gender is not limited;
  • •Clinically confirmed MSA and clinically probable MSA according to the 2022 MDS MSA diagnostic criteria;
  • •all patients had been ruled out of polyQ disease by genetic testing;
  • •Voluntarily participate in this study and sign the informed consent form.

排除标准

  • •pregnancy or breastfeeding;
  • •contraindications to MRI examination or inability to cooperate in completing neuroimaging examination;
  • •previous history of other neurological disorders or presence of other organic intracranial lesions on neuroimaging that cannot be interpreted by MSA, such as epilepsy, trauma, tumors, or high-grade cerebral white matter degeneration (Fazekas grade 2 and above);
  • •History of alcohol or drug abuse

结局指标

主要结局

Standard uptake value ratio(SUVR)

时间窗: From enrollment to the end of treatment at 4 weeks

次要结局

  • H-Y stage(From enrollment to the end of treatment at 4 weeks)
  • Wexner score(From enrollment to the end of treatment at 4 weeks)
  • UMSARS(From enrollment to the end of treatment at 4 weeks)
  • SCOPA-AUT(From enrollment to the end of treatment at 4 weeks)
  • Frontal Assessment Battery(From enrollment to the end of treatment at 4 weeks)
  • MoCA score(From enrollment to the end of treatment at 4 weeks)
  • TSPO Single nucleotide polymorphism genotyping(From enrollment to the end of treatment at 4 weeks)

研究者

发起方
Min Zhao,MD
申办方类型
Other

研究点 (1)

Loading locations...

相似试验